Aems

Concentrated-biologic viscosity can only be measured rather than calculated, and the candidate combinations exceed what any single testing program can cover. Aems designs and runs high-throughput experiments to find formulations for concentrated biologics using excipients already approved in marketed drug products, and it screens at high throughput on small amounts of material while building predictive tools from its own screening data.

Aems screens only excipients already approved in marketed drugs and avoids enzymes and polymers in its viscosity-reduction approach, and testing mixtures in different proportions lets it examine combinations that changing one ingredient at a time can miss. It is looking for development teams, funders and research collaborators to help build its predictive capability.